[1P-049（2T04a-09）] Therapeutic effects of overexpression of lysophosphatidylcholine acyltransferase 4 (LPCAT4)/lysophospholipid acyltransferase 10 (LPLAT10) in the liver on glucose metabolism

^〇Kahori Shimizu¹, Moe Ono¹, Takenari Mikamoto¹, Yuya Urayama¹, Hiroki Nakanishi², Tomoyuki Terada¹, Fuminori Sakurai³, Hiroyuki Mizuguchi^3,4,5,6, Hideo Shindou^7,8, Koji Tomita¹, Toru Nishinaka¹ (1.Faculty of Pharmacy, Osaka Ohtani University, 2.Lipidome Lab Company, Limited., 3.Graduate School of Pharmaceutical Sciences, Osaka University, 4.National Institute of Biomedical Innovation, Health and Nutrition, 5.Global Center for Medical Engineering and Informatics, Osaka University, 6.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), 7.National Center for Global Health and Medicine, 8.Graduate School of Medicine, The University of Tokyo)

キーテクノロジー：アデノウイルスベクター

リゾリン脂質アシル転移酵素、糖代謝、糖尿病、アデノウイルスベクター、肝臓